Search Results

Kelo-Cote Spray is a topical silicone spray intended for the management of old and new hypertrophic and keloid scarring on scars resulting from burns, general surgical procedures and trauma wounds.

Kelo-Cote Spray is a lightweight, self-drying silicone gel spray for the treatment of scars. Upon drying, the silicone gel layer forms a film for the management of scars. The components of Kelo-Cote Spray include fumed silica and silicone elastomer, liquid, and gum. It is provided in a can with a spray nozzle for application purposes.

The provided text is a 510(k) premarket notification for a medical device called Kelo-Cote Spray. This type of submission is for demonstrating substantial equivalence to a legally marketed predicate device, rather than proving safety and effectiveness through clinical trials with specific acceptance criteria.

Therefore, the document does not contain the information requested regarding acceptance criteria, study details, sample sizes, expert ground truth, or comparative effectiveness studies.

Specifically, the following points cannot be addressed from the given text:

1. A table of acceptance criteria and the reported device performance: Not present. The submission focuses on substantial equivalence.
2. Sample sizes used for the test set and the data provenance: Not present. No test set described.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not present. No ground truth establishment described.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set: Not applicable, no test set described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This is not an AI device, and no MRMC study is described.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: Not applicable, this is not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): Not present.
8. The sample size for the training set: Not applicable, no training set for an algorithm described.
9. How the ground truth for the training set was established: Not applicable.

The submission states: "ABT believes Kelo-Cote Spray is substantially equivalent to legally marketed products: ABT's Kelo-Cote Topical Gel (K002488) and the Curad Spray Bandage (K022645)." and further clarifies that "The ABT Kelo-Coat Topical Gel provides a substantial equivalence basis for the intended use and components of Kelo-Coat Spray. The Curad Spray Bandage provides a substantial equivalence basis for the method of application of Kelo-Cote Spray." This indicates that rather than new studies, the equivalence is based on existing, predicate devices.

Ask a specific question about this device